Discussing the FDA Scientific & Regulatory Considerations for Bacteriophage Therapies

Time: 9:10 am
day: Day One

Details:

  • Regulatory Considerations for Bacteriophage Therapy
  • FDA green lights study of phage-based drug for resistant infections

Speakers: